Seagen to Present at the J.P. Morgan Healthcare Conference-December 20, 2022


BOTHELL, Wash.--(BUSINESS WIRE)--Seagen, Inc.. (Nasdaq:SGEN) today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 3:00 p.m. Pacific Time. The presentation will be webcast live and available for replay from the investor section of Seagen’s website at

About Seagen

Seagen is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company’s marketed products and robust pipeline, visit and follow @SeagenGlobal on Twitter.


For Investors
Douglas Maffei, Ph.D.
(425) 527-4881

For Media
David Caouette
(310) 430-3476


Source: Seagen Inc.

Back to news